with carotid atherosclerosis. We investigated the association between HCV seropositivity and acute myocardial infarction using a well-established cohort of young men in the US military and found no evidence to support this association.
for у1 year before the onset of myocardial infarction. Control subjects were men with no history of hospitalization for cardiovascular disease (ICD-9 codes 410-429) before the date of the case event and were individually matched to case patients by age ‫1ע(‬ year), race/ethnicity ("white, non-Hispanic," "black, non-Hispanic," and "other"), and availability of a serum specimen that had been collected within 60 days of collection of the case patient's specimen.
Information on health risk factors was obtained from the health risk appraisal, which included self-reported information on past and current smoking habits, work stress, and diabetes, as well as measurements for height, weight, blood pressure, and serum cholesterol level [9] . The health risk appraisal is completed by military personnel at the time of entry into the military, every 2 years thereafter, and at every 5-year physical examination. The health risk appraisal closest in date to the serum specimen was selected for analysis.
Serum samples were obtained from the Department of Defense serum repository, which was created to store all serum samples that remain from the mandatory HIV testing program. Serum specimens were tested for the presence of HCV-specific antibodies using the commercially available Ortho ELISA, version 3.0 (Ortho Clinical Diagnostics), in accordance with manufacturer's instructions. Samples that had an optical density reading 0.1 above or below the assay cutoff were repeated. Chlamydia pneumoniae IgG and IgA antibodies were measured by microimmunofluorescence assay [10] ; a high titer was defined as у1:256 for C. pneumoniae IgG and as у1:64 for C. pneumoniae IgA on the basis of previous literature and expert opinion [11, 12] .
Statistical analyses were performed using SAS software, version 8.01 (SAS Institute). The 2-sample t test and the x 2 test were used to examine differences in demographic characteristics between case patients and control subjects and to assess potential confounding variables. Multivariate logistic regression was conducted to study the relationship between case-control status, infection status, and demographic characteristics and cardiovascular risk factors [13] . Variable selection for final models was based on the likelihood ratio test. Because HCV test results were not available for the entire study population, unconditional regression analyses were conducted to maximize statistical power; however, the matching variables (age and race) were included in all final models to partially account for matching and to control for residual confounding. The study was reviewed and approved by the institutional review boards at Johns Hopkins University (Baltimore, MD) and the Walter Reed Army Institute of Research (Silver Spring, MD).
Results. HCV test results and demographic data were available for 292 case patients (97.3%) and 290 control subjects (96.7%). By design, there were no differences between case patients and control subjects with respect to age (mean age, 40.2 years) and race/ethnicity (61.0% were white), and there were no significant differences with respect to military rank (69.8% were Senior Enlisted/Officer overall); however, case patients tended to be less educated (63.0% reported having only a high school education, compared with 51.0% of control subjects;
) and were more likely to be married (93.8%) than P ! .01 were control subjects (86.6%; ) (table 1) . P ! .01 Overall, 52 participants tested positive for anti-HCV antibodies, a prevalence of 8.9% (table 1) . A significant increased prevalence was observed among black, non-Hispanic subjects (13.2%), compared with white, non-Hispanic subjects (6.8%) and with subjects from other ethnic groups (9.4%;
). P ! .05 There was no significant difference in the prevalence of HCV infection between case patients (7.6%) and control subjects (9.8%;
). No association was found between HCV pos-P p .44 itivity and acute myocardial infarction (relative risk [RR], 0.91; 95% CI, 0.52-1.61). This estimate remained essentially unchanged after adjustment for age, race, education, and marital status (adjusted RR, 0.94; 95% CI, 0.52-1.68) (table 2).
As reported in detail elsewhere [8] , a larger proportion of study participants were found to have a high titer of C. [5] reported that HCV seropositivity represented an independent predictor of coronary artery disease after adjusting for confounding risk factors (OR, 4.2; 95% CI, 1.4-13.0). The previously reported associations observed in all 3 studies [5] [6] [7] between markers of HCV infection and coronary artery disease were stronger than the associations shown for all other established risk factors presented, including male sex, increasing age, hypertension, cholesterol, and smoking status. It seems unlikely that an association between HCV infection and coronary artery disease would be stronger than associations with established risk factors.
In the studies by Ishizaka et al. [6, 7] , the study populations appeared to be healthy individuals who were enrolled during a general health screening. The study by Vassalle et al. [5] used hospital-based case patients and control subjects. Details were not provided on subject selection; this limits the interpretation and generalizability of results. A wide range of ages among the study populations may further complicate analysis, particularly in the study by Vassalle and colleagues, in which control subjects appeared to be younger than case patients. Infections may only play a role in coronary heart disease during particular stages of the natural history of atherosclerosis. All 3 studies were unable to establish the temporal sequence of infection and coronary artery disease. Previous publications have not discussed the putative biological basis for an association between HCV infection and coronary heart disease.
The results of the present study agree with a study conducted by Kiechl et al. [14] , who showed no association between chronic active hepatitis B virus and/or HCV infection and carotid plaque. Furthermore, the C. pneumoniae IgG and IgA data in the present study are consistent with those in the published literature [11] .
Although samples with an optical density reading of 0.1 above or below the assay cutoff value were repeated, a limitation of our study was that confirmatory HCV testing was not performed; it is possible that some of the low positive values are false-positive results. Because low positive values (signal-to-cutoff ratio, !3.8) were evenly distributed between case patients and control subjects, they would not bias the results of any association between HCV infection and acute myocardial infarction.
The prevalence of antibody to HCV in the general US population is estimated to be 1.8% [15] . A large study of the general civilian population of the United States found that the prevalence of HCV infection among persons who had served in the military (1.7%) was similar to the prevalence among persons who had not served in the military (2.2%) [15] . Hyams et al. [16] performed a study of 10,000 randomly selected, activeduty personnel and reported a prevalence of HCV infection of 0.5% overall, with a prevalence of 1.2% among persons aged у30 years. Among users of the Veterans Administration (VA) health care system, a high prevalence of HCV infection (4%-35%) has been reported [17] . However, VA hospital users have been shown to be demographically very different from the general US population and from veterans who do not use the VA system [17] . A high prevalence of HCV infection (8.9%) was observed in this study population of active-duty US military personnel. However, even if we assume that a signal-to-cutoff ratio !3.8 generally represents false-positive results, the prevalence of HCV infection in the study population would be 4.0%, with the highest prevalence occurring in non-Hispanic black subjects; this finding would be similar to those in the study by Hyams et al. [16] .
Although there is a high prevalence of HCV infection in the study population, this translated to only 52 HCV-positive participants, and the 95% CIs around the estimate are wide. It should also be noted that the study population is not reflective of the characteristics of most people with acute myocardial infarction in the United States. Active duty military personnel tend to be in overall good health, and the age range is much lower than the average age of a patient with acute myocardial infarction. It is possible that some of the control subjects in our study may have had asymptomatic coronary heart disease or will experience a future hospitalization for acute myocardial infarction. The resulting misclassification would result in conservative RR estimates (i.e., closer to the null hypothesis) but would not explain an RR !1.0 if, in fact, HCV infection was a risk factor.
In summary, the present study conducted with active-duty military personnel who had a high prevalence of HCV infection does not support a relationship between HCV infection and coronary heart disease.
